Solventum Corporation (SOLV) Stock Price

SOLVStock

$91.12+25.41%52W

Market Cap$15.51B

P/E9.46x

PEG Ratio1.22

Div yield—

Beta0.45

SOLV Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)12.18%

Price vs S&P 500 (4W)1.92%

PEG Ratio1.22

VGM Score59.35

P/E Ratio (Annual)9.46x

P/CF (Annual)39.88x

Book Value / Share (Quarterly)$28.22

P/TBV (Annual)5.59x

Revenue Growth (3Y)0.79%

Cash Flow / Share (Quarterly)$-0.68

Price vs S&P 500 (YTD)2.17%

Gross Margin (TTM)54.78%

Net Profit Margin (TTM)17.27%

EPS (TTM)$8.19

10-Day Avg Trading Volume0.99M

EPS Excl Extra (TTM)$8.19

EPS (Annual)$8.88

ROI (Annual)15.43%

Gross Margin (Annual)54.23%

Net Profit Margin (5Y Avg)15.06%

Cash / Share (Quarterly)$2.37

P/E Basic Excl Extra (TTM)10.26x

Revenue Growth QoQ (YoY)2.22%

P/E Normalized (Annual)9.46x

ROA (Last FY)10.89%

Revenue Growth TTM (YoY)-0.93%

EBITD / Share (TTM)$14.22

ROE (5Y Avg)16.41%

Operating Margin (TTM)23.86%

Cash Flow / Share (Annual)$-0.06

P/B Ratio3.07x

P/B Ratio (Quarterly)2.78x

Net Income / Employee (Annual)$77,800

EV / Revenue (TTM)2.36x

Net Interest Coverage (TTM)6.10x

ROA (TTM)10.14%

EPS Growth QoQ (YoY)4.46%

EV / EBITDA (TTM)7.87x

EPS Incl Extra (Annual)$8.88

Current Ratio (Annual)1.23x

Quick Ratio (Quarterly)0.70x

3-Month Avg Trading Volume1.52M

52-Week Price Return25.41%

EV / Free Cash Flow (Annual)20.33x

P/E Incl Extra (TTM)10.26x

Revenue / Employee (TTM)$415,500

Tangible BV / Share (Quarterly)$14.06

P/S Ratio (Annual)1.77x

Asset Turnover (Annual)0.58x

52-Week High$92.71

Operating Margin (5Y Avg)20.42%

EPS Excl Extra (Annual)$8.88

26-Week Price Return24.11%

Quick Ratio (Annual)0.84x

13-Week Price Return19.99%

Total Debt / Equity (Annual)1.00x

Current Ratio (Quarterly)1.02x

Enterprise Value$19.60B

Asset Turnover (TTM)0.59x

Revenue / Employee (Annual)$416,300

Inventory Turnover (Annual)3.75x

Pretax Margin (Annual)20.58%

Cash / Share (Annual)$5.06

3-Month Return Std Dev34.71%

Gross Margin (5Y Avg)57.07%

Net Income / Employee (TTM)$71,700

ROE (Last FY)30.82%

Net Interest Coverage (Annual)7.65x

EPS Basic Excl Extra (Annual)$8.88

P/FCF (TTM)83.62x

Receivables Turnover (TTM)7.00x

EV / Free Cash Flow (TTM)327.30x

Total Debt / Equity (Quarterly)1.10x

EPS Incl Extra (TTM)$8.19

Receivables Turnover (Annual)8.01x

ROI (TTM)14.16%

P/S Ratio (TTM)1.77x

Pretax Margin (5Y Avg)18.42%

Revenue / Share (Annual)$47.49

Tangible BV / Share (Annual)$14.16

Forward P/E12.73x

Price vs S&P 500 (52W)6.85%

P/E Ratio (TTM)10.26x

EPS Growth TTM (YoY)277.11%

Year-to-Date Return14.99%

5-Day Price Return-0.14%

EPS Normalized (Annual)$8.88

ROA (5Y Avg)8.82%

Net Profit Margin (Annual)18.69%

Month-to-Date Return6.65%

EBITD / Share (Annual)$14.70

EPS Growth (3Y)4.46%

Operating Margin (Annual)25.08%

LT Debt / Equity (Annual)1.00x

P/CF (TTM)69.75x

ROI (5Y Avg)10.98%

P/E Excl Extra (TTM)10.26x

LT Debt / Equity (Quarterly)0.95x

EPS Basic Excl Extra (TTM)$8.19

P/TBV (Quarterly)5.59x

P/B Ratio (Annual)2.72x

Inventory Turnover (TTM)3.75x

Pretax Margin (TTM)20.41%

Book Value / Share (Annual)$29.10

Price vs S&P 500 (13W)18.03%

Beta0.45x

P/FCF (Annual)18.28x

Revenue / Share (TTM)$47.95

ROE (TTM)28.98%

52-Week Low$62.38

vGradeC

gGradeC

mGradeB

vgmGradeC

SOLV Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 5, 2026	$1.91	$2.55	+33.78%(+$0.64)
Q1 2026	May 5, 2026	$1.35	$1.48	+9.33%(+$0.13)
Q4 2025	Feb 26, 2026	$1.50	$1.57	+5.00%(+$0.07)
Q3 2025	Nov 6, 2025	$1.43	$1.50	+4.73%(+$0.07)
Q2 2025	Aug 7, 2025	$1.45	$1.69	+16.25%(+$0.24)

SOLV Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.67

3.73

3.82

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
SOLVSolventum Corporation	C	C	B	$91.12
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About Solventum Corporation

Solventum is a diversified healthcare company providing innovative medical solutions across three core areas: wound care and surgical supplies, dental products, and health information systems. The company leverages material science, data science, and digital technologies to serve hospitals, dental practices, and healthcare providers. Solventum generates the majority of its revenue in the United States while maintaining a growing international presence.